Pharmaceuticals
NPPA slashes cancer drug prices by up to 86%
07 Mar 2017
Since March 2016, there has been "significant price reduction" by up to 86 per cent in some major cancer drugs, and by up to 42 per cent in major diabetic drugs, the drug prices regulator said
